News

Final Results and Post Year-End Update

May 19, 2022
Verici Dx plc announces its audited final results for the period ended 31 December 2021
Keep Reading

Positive results for Tutivia™ from the international clinical validation study

May 12, 2022
Performance in blinded multi-centre trial establishes new industry standard in detection of acute kidney transplant rejection and paves way for commercial launch in United States in 2022
Keep Reading

Clinical Validation Study Update

April 1, 2022
Strategic decision to expand study without impacting commercial pathway
Keep Reading

TR-1: Standard form for notification of major holdings

March 23, 2022
Notification of major holdings
Keep Reading

TR-1: Standard form for notification of major holdings

March 21, 2022
Notification of major holdings
Keep Reading

TR-1: Standard form for notification of major holdings

March 18, 2022
Notification of major holdings
Keep Reading

TR-1: Standard form for notification of major holdings

March 16, 2022
Notification of major holdings
Keep Reading

TR-1: Standard form for notification of major holdings

March 15, 2022
Notification of major holdings
Keep Reading

Close of Subscription and Fundraise Update

March 11, 2022
The Subscription has now closed and the Fundraise has successfully concluded, save for Admission.
Keep Reading

Fundraise - Successful Placing

March 4, 2022
Verici Dx is pleased to announce the successful completion of the Placing.
Keep Reading

Archived News

crossmenuchevron-down